NCT03481582View on ClinicalTrials.gov

Effect of Nitric Oxide Donors on Uterine and Subendometrial Blood Flow in Patients With Unexplained Infertility

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

March 1, 2018

Study Completion Date

March 1, 2018

Conditions
Polycystic Ovary SyndromeInfertility, Female
Interventions
DRUG

Nitroglycerin

(nitrodermal®) 5 mg (patch)as a source of Nitric oxide from 2nd day of cycle till maturation of the follicles ≥ 18 mm just for one cycle.

DEVICE

Three dimensional power doppler

Once the follicle reached ≥18 mm 3D power Doppler will be used to assess the uterine and subendometrial blood flow

Trial Locations (1)

11591

Department of obstetrics and gynaecology, faculty of medicine, Ain shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03481582 - Effect of Nitric Oxide Donors on Uterine and Subendometrial Blood Flow in Patients With Unexplained Infertility | Biotech Hunter | Biotech Hunter